CDC International Capital Overview

  • Investor Type
  • PE/​Buyout

  • Status
  • Inactive

  • Professionals
  • 1

Professionals

  • Investments
  • 52

  • Portfolio
  • 3

  • Exits
  • 9

Exits

CDC International Capital General Information

Company Description

Founded in 2014, CDC International Capital was a private equity arm of Caisse des Dépôts Group and was headquartered in Paris, France. The firm sought investments in companies operating in healthcare, information technology, financial services, TMT, industrials, infrastructure, and lohas & wellness sectors across France. In December 2018 the firm was acquired by Bpifrance.

Business Details

Year Founded
2014
Investor Status
Acquired/Merged
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
PE/Buyout
Other Investor Types
Fund of Funds
Growth/Expansion
Venture Capital
Corporate Office
  • 67 rue de Lille
  • 75007 Paris
  • France

CDC International Capital Investments (52)

CDC International Capital’s most recent investment was a with Mitsubishi Tanabe Pharma (Argatroban Business in Europe). The deal was made on 13-Jun-2024.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Mitsubishi Tanabe Pharma (Argatroban Business in Europe) 13-Jun-2024 Buildings and Property Generating Revenue
Info-Presse 15-Nov-2023 Internet Retail Generating Revenue
Solution Net Systems 03-Apr-2023 Business/Productivity Software Generating Revenue
Clinique Saint-François (Hospitals/Inpatient Services) 14-Oct-2021 Hospitals/Inpatient Services Generating Revenue
Altan Pharma 01-Oct-2021 Buyout/LBO Drug Discovery Generating Revenue
You’re viewing 5 of 52 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CDC International Capital Exits (9)

CDC International Capital has made a total of 9 exits. Its latest exit was from Ethypharm on 01-Aug-2024. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size
Ethypharm 01-Aug-2024
Arc 1825 01-May-2024
Cityscoot 30-Nov-2023
Vulcanic 30-Sep-2022
Vivalto Sante 30-Nov-2021 Buyout/LBO
You’re viewing 5 of 9 exits. Get the full list »

CDC International Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

CDC International Capital FAQs

  • What is CDC International Capital?

    Founded in 2014, CDC International Capital was a private equity arm of Caisse des Dépôts Group and was headquartered in Paris, France.

  • When was CDC International Capital founded?

    CDC International Capital was founded in 2014.

  • Where is CDC International Capital headquartered?

    CDC International Capital is headquartered in Paris, France.

  • What is CDC International Capital's total asset value?

    CDC International Capital has around in total assets under management.

  • How many investments has CDC International Capital made?

    CDC International Capital has made 52 investments.

  • What has CDC International Capital invested in?

    CDC International Capital has made numerous investments in companies like Mitsubishi Tanabe Pharma (Argatroban Business in Europe), Info-Presse, and Solution Net Systems within the Buildings and Property, Internet Retail, and Business/Productivity Software industries.

  • What has CDC International Capital invested in recently?

    CDC International Capital's latest investment was on 13-Jun-2024 in Mitsubishi Tanabe Pharma (Argatroban Business in Europe), a company within the Buildings and Property industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process